July 7, 2021 -- Gyros Protein Technologies has introduced its new HEK 293 host cell protein (HCP) immunoassay solution in collaboration with Cygnus Technologies. The Cygnus HEK 293 HCP Assay Reagent Set for Gyrolab is a ready-to-use bioprocess impurity reagent set optimized for use with the Gyrolab automated immunoassay platform.
The new kit is designed for use with the Gyrolab Bioaffy 1000HC Toolbox and detects residual HCP from HEK 293 cells, a cell line commonly used in viral vector production for cell and gene therapies as well as in the manufacturing of vaccines. The automated, nanoliter-scale immunoassay allows for streamlined process transfer, increased productivity, and reduced sample volume and reagent consumption, according to the firms.
The announcement follows the launch of the ready-to-use Gyrolab CHO HCP and E. coli HCP kits, developed through a licensing and supply agreement with Cygnus.
Financial details of the collaboration were not disclosed.